EEG
SRPT icon

E.E. Geduld’s Sarepta Therapeutics SRPT Stock Holding History

E.E. Geduld’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$302K Sell
11,000
-19,359
-64% -$778K 0.17% 52
2016
Q3 		$1.86M Buy
30,359
+5,359
+21% +$162K 1.86% 7
2016
Q2 		$477K Buy
+25,000
New +$463K 0.63% 27
2014
Q1 		– Sell
-40,000
Closed -$815K – 334
2013
Q4 		$815K Buy
40,000
+25,000
+167% +$743K 0.39% 49
2013
Q3 		$708K Buy
+15,000
New +$578K 0.43% 51

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

E.E. Geduld's SRPT Position: Q4 2016 in Review

E.E. Geduld reduced its Sarepta Therapeutics (SRPT) stake by 64% in Q4 2016, selling an estimated $778K and leaving 11,000 shares worth $302K. The position accounts for 0.17% of the portfolio, ranked #52.

E.E. Geduld first reported a position in SRPT in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.86M in Q3 2016. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • E.E. Geduld held 11,000 shares of Sarepta Therapeutics worth $302K as of Q4 2016.
  • E.E. Geduld sold 19,359 Sarepta Therapeutics shares in Q4 2016, an estimated $778K.
  • Sarepta Therapeutics made up 0.17% of E.E. Geduld's portfolio in Q4 2016, its #52 holding.
  • E.E. Geduld first reported a position in Sarepta Therapeutics in Q3 2013 and has held it in 5 quarters since.
  • E.E. Geduld's Sarepta Therapeutics position peaked at $1.86M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.